a company which translates genome editing technology into a novel class of human therapeutics
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JSVZX | 27.43 | 0.39 | +1.44% |
JPMorgan Small Cap Value R2 | |||
JLVRX | 23.25 | 0.33 | +1.44% |
JPMorgan Large Cap Value R5 | |||
ADGGX | 31.76 | 0.12 | +0.38% |
American Century Disciplined Growth R5 | |||
NUIIX | 29.48 | 0.06 | +0.20% |
Nuveen International Dividend Growth I | |||
GSZPX | 28.45 | N/A | N/A |
Goldman Sachs Small Cap Gr Insghts P |
A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with NTLA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To EDIT | 1D Price Change % | ||
---|---|---|---|---|
EDIT | 100% | -1.66% | ||
NTLA - EDIT | 64% Loosely correlated | +5.18% | ||
CRSP - EDIT | 64% Loosely correlated | -2.05% | ||
BEAM - EDIT | 64% Loosely correlated | -3.72% | ||
VERV - EDIT | 54% Loosely correlated | +1.10% | ||
AXON - EDIT | 52% Loosely correlated | +3.52% | ||
More |